- Human pathology

Home > D. General pathology > Therapy, Toxics and drugs > gefitinib


Wednesday 6 June 2007

Gefitinib is one of EGFR tyrosine kinase inhibitors (TKI / TKIs ).

See also

- EGFR-associated NSCLC


- Herbst RS, Fukuoka M, Baselga J. Gefitinib—a novel targeted approach to treating cancer. Nat Rev Cancer. 2004 Dec;4(12):956-65. PMID: 15573117


- Gefitinib Yields Superior Outcomes vs Chemotherapy in EGFR-Mutation-Positive NSCLC, Maurie Markman, MD, Medscape, Posted: 06/03/2010